Tumor necrosis factor receptor superfamily member 10C (Antagonist decoy receptor for TRAIL/Apo-2L) (Decoy TRAIL receptor without death domain) (Decoy receptor 1) (DcR1) (Lymphocyte inhibitor of TRAIL) (TNF-related apoptosis-inducing ligand receptor 3) (TRAIL receptor 3) (TRAIL-R3) (TRAIL receptor without an intracellular domain) (CD antigen CD263)
1_MARIP 6_ KTLKF 11_ VVVIV 16_ AVLLP 21_ VLAYS 26_ ATTAR 31_ QEEVP 36_ QQTVA 41_ PQQQR 46_ HSFKG 51_ EECPA 56_ GSHRS 61_ EHTGA 66_ CNPCT 71_ EGVDY 76_ TNASN 81_ NEPSC 86_ FPCTV 91_ CKSDQ 96_ KHKSS 101_ CTMTR 106_ DTVCQ 111_ CKEGT 116_ FRNEN 121_ SPEMC 126_ RKCSR 131_ CPSGE 136_ VQVSN 141_ CTSWD 146_ DIQCV 151_ EEFGA 156_ NATVE 161_ TPAAE 166_ ETMNT 171_ SPGTP 176_ APAAE 181_ ETMNT 186_ SPGTP 191_ APAAE 196_ ETMTT 201_ SPGTP 206_ APAAE 211_ ETMTT 216_ SPGTP 221_ APAAE 226_ ETMIT 231_ SPGTP 236_ ASSHY 241_ LSCTI 246_ VGIIV 251_LIVLL
1: Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand